Webinar

Navigating the regulatory complexities of targeted medicines in oncology

  • PharmaLex, a Cencora company

 In this webinar, Chris Englerth, our Director of Global Consulting Services, moderates the session alongside Christian Schneider, MD, our Chief Medical Officer for Strategic Product Development Consulting. The future of targeted medicines holds promise, and as the landscape continues to evolve, understanding key non-clinical and clinical considerations is more critical than ever. Watch the webinar to explore the strategic considerations for successfully navigating the regulatory complexities of targeted medicines.
webinar banner

Key learnings

webinar banner
  • An introduction and understanding of targeted medicines
  • The challenge in translational medicine for non-clinical development of targeted medicines
  • Key clinical development considerations of targeted medicines
webinar banner

 

Fill out the form to access the webinar recording

Pardot Form

PharmaLex joins Cencora

PharmaLex is now part of Cencora, a global leader in pharmaceutical solutions focused on improving lives worldwide. This integration enhances Cencora’s offerings for the pharma, biotech, and medtech industries. PharmaLex support clients from early strategic planning and non-clinical requirements through clinical development, regulatory submissions, and post-approval activities, utilizing technology-driven solutions throughout the product lifecycle.

Related resources

Article

PDABs: An imperfect solution to a complex issue

Webinar

Implementing risk-based quality review for an inspection-ready TMF

Factsheet

Migrate your TMF